| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,060 |
9,116 |
$45K |
| 64483 |
|
106 |
106 |
$25K |
| 77003 |
|
149 |
149 |
$12K |
| 64484 |
|
106 |
106 |
$11K |
| 72275 |
|
109 |
109 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
119 |
118 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
119 |
118 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,834 |
4,212 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,281 |
2,093 |
$618.39 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,309 |
2,832 |
$439.32 |
| A4267 |
Contraceptive supply, condom, male, each |
15 |
14 |
$216.02 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
142 |
120 |
$81.06 |
| 81025 |
|
14 |
14 |
$39.20 |
| 86592 |
|
157 |
155 |
$21.70 |
| 87210 |
|
17 |
13 |
$14.24 |
| 82540 |
|
1,383 |
1,360 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
631 |
556 |
$0.00 |
| 99442 |
|
4,909 |
4,574 |
$0.00 |
| 80061 |
Lipid panel |
4,589 |
4,577 |
$0.00 |
| 82274 |
|
691 |
679 |
$0.00 |
| 86703 |
|
1,046 |
1,042 |
$0.00 |
| 3078F |
|
1,363 |
1,239 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
393 |
361 |
$0.00 |
| 86480 |
|
54 |
52 |
$0.00 |
| 3077F |
|
373 |
340 |
$0.00 |
| 83540 |
|
150 |
142 |
$0.00 |
| 99242 |
|
15 |
15 |
$0.00 |
| 85610 |
|
199 |
179 |
$0.00 |
| 84439 |
|
152 |
151 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
203 |
200 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
639 |
326 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
151 |
150 |
$0.00 |
| 91300 |
|
21 |
18 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
116 |
116 |
$0.00 |
| 90715 |
|
48 |
47 |
$0.00 |
| 86900 |
|
12 |
12 |
$0.00 |
| 86765 |
|
27 |
27 |
$0.00 |
| 81003 |
|
59 |
59 |
$0.00 |
| 1033F |
|
151 |
149 |
$0.00 |
| 85014 |
|
24 |
24 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$0.00 |
| 3046F |
|
12 |
12 |
$0.00 |
| 99201 |
|
35 |
34 |
$0.00 |
| 99173 |
|
18 |
12 |
$0.00 |
| 82565 |
|
12 |
12 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,583 |
1,542 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
206 |
198 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
5,624 |
5,177 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,674 |
4,656 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
10,923 |
9,780 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,347 |
1,333 |
$0.00 |
| 99441 |
|
1,634 |
1,559 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
831 |
780 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
883 |
874 |
$0.00 |
| 87340 |
|
105 |
105 |
$0.00 |
| 81000 |
|
156 |
142 |
$0.00 |
| 82043 |
|
1,383 |
1,360 |
$0.00 |
| 85027 |
|
1,941 |
1,867 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,984 |
3,661 |
$0.00 |
| 1220F |
|
1,722 |
1,691 |
$0.00 |
| 81001 |
|
383 |
370 |
$0.00 |
| 4450F |
|
843 |
835 |
$0.00 |
| 86901 |
|
12 |
12 |
$0.00 |
| 3080F |
|
225 |
211 |
$0.00 |
| 83735 |
|
507 |
346 |
$0.00 |
| 90686 |
|
201 |
201 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
329 |
326 |
$0.00 |
| 86780 |
|
262 |
261 |
$0.00 |
| 3075F |
|
349 |
335 |
$0.00 |
| 99443 |
|
219 |
216 |
$0.00 |
| 92227 |
|
38 |
38 |
$0.00 |
| 82728 |
|
315 |
305 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
204 |
201 |
$0.00 |
| 86141 |
|
204 |
202 |
$0.00 |
| 1000F |
|
271 |
264 |
$0.00 |
| 87088 |
|
119 |
112 |
$0.00 |
| 3044F |
|
452 |
452 |
$0.00 |
| 85008 |
|
245 |
220 |
$0.00 |
| 90656 |
|
145 |
145 |
$0.00 |
| 85652 |
|
133 |
131 |
$0.00 |
| 84153 |
|
28 |
28 |
$0.00 |
| 82607 |
|
153 |
151 |
$0.00 |
| 1111F |
|
424 |
386 |
$0.00 |
| 83550 |
|
93 |
89 |
$0.00 |
| 3074F |
|
1,299 |
1,192 |
$0.00 |
| 85018 |
|
24 |
24 |
$0.00 |
| 2001F |
|
90 |
88 |
$0.00 |
| 3079F |
|
472 |
454 |
$0.00 |
| 92250 |
|
12 |
12 |
$0.00 |
| 86850 |
|
12 |
12 |
$0.00 |